We are pleased to share the latest advancement from ACD / Bio-Techne: the launch of their RNAscope™ Professional Assay Services, designed to accelerate therapeutic development through cutting-edge spatial analysis.
About RNAscope Professional Assay Services
The RNAscope technology is a state-of-the-art in situ hybridization method that allows researchers to visualize and quantify RNA within intact tissues at single-cell resolution. With the support of Bio-Techne’s expert services team, scientists can now access specialized assays and analysis workflows that provide deeper insights into disease biology and drug response.
- Spatial profiling of targets – antigens, biomarkers, cytokines, CAR-T cells, and immune cell distribution in the tumor microenvironment.
- Neurology-focused insights – visualization of cell-type specific and subcellular localization in defined brain regions.
- Customized image analysis – powerful tools for precise and flexible quantification of markers.
Accelerating Drug Development
By combining advanced spatial biology with professional support, RNAscope services help researchers move faster from early discovery to clinical development. This approach delivers clarity in complex tissue dynamics and enhances decision-making in oncology, neurology, and beyond.
Expert Presenters
- Xiomara A. Perez, Ph.D. – Professional Assay Services
- Farhat Mustafa, M.D. – Professional Assay Services
Their presentations highlighted how RNAscope can support therapeutic pipelines by providing robust, reproducible, and clinically relevant insights.
Learn More
📺 Watch Now – [Insert replay link]
🌐 Visit Bio-Techne – [Insert official website link]
✨ With these expert services, RNAscope continues to redefine spatial biology, empowering scientists with actionable data to advance the next generation of therapies.